Funding
PROSTATE
Exosome Diagnostics, the developer and owner of the ExoDx Prostate IntelliScore (EPI) exosome gene expression assay used in this study, provided all financial and material support for the work reported in this article. Exosome Diagnostics, Inc. paid for all validation studies.